Box score
Superluminal Medicines, Inc.
Reported $65.5M sold in a new Form D filed September 3, 2026 (Boston, Massachusetts).
- Biggest raise
- $65.5M filed Sep 3, 2026
- League
- Bio & Health Biotechnology
- Based in
- Boston, Massachusetts
- Season rank
- #31 of 1,121 in the Bio & Health League; #363 of 10,745 overall (2026)
- Incorporated
- 2023
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-09-03 | New notice | $65.5M | $65.5M | SEC |
| 2025-08-26 | New notice | $5M | $5M | SEC |
| 2024-09-04 | New notice | $20M | $120M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1989478.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Alzheon, Inc. | Bio & Health | $78.8M |
| 2 | Ratio Therapeutics, Inc. | Bio & Health | $70M |
| 3 | Stipple Bio, Inc. | Bio & Health | $65.1M |
| 4 | Terrestrial Bio, Inc. | Bio & Health | $57.3M |
| 5 | Typewriter Therapeutics, Inc. rookie | Bio & Health | $56.3M |
| 6 | Cue Biopharma, Inc. | Bio & Health | $50M |